Pressure BioSciences Past Earnings Performance
Past criteria checks 0/6
Pressure BioSciences's earnings have been declining at an average annual rate of -12.4%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been declining at an average rate of 0.1% per year.
Key information
-12.4%
Earnings growth rate
44.1%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | -0.1% |
| Return on equity | n/a |
| Net Margin | -2,308.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Pressure BioSciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2 | -37 | 7 | 1 |
| 31 Dec 23 | 2 | -35 | 9 | 1 |
| 30 Sep 23 | 2 | -30 | 6 | 1 |
| 30 Jun 23 | 2 | -28 | 6 | 1 |
| 31 Mar 23 | 2 | -20 | 6 | 1 |
| 31 Dec 22 | 2 | -18 | 4 | 1 |
| 30 Sep 22 | 1 | -17 | 4 | 1 |
| 30 Jun 22 | 2 | -19 | 4 | 1 |
| 31 Mar 22 | 2 | -20 | 4 | 1 |
| 31 Dec 21 | 2 | -23 | 4 | 1 |
| 30 Sep 21 | 2 | -23 | 4 | 1 |
| 30 Jun 21 | 2 | -21 | 4 | 1 |
| 31 Mar 21 | 2 | -20 | 4 | 1 |
| 31 Dec 20 | 1 | -18 | 4 | 1 |
| 30 Sep 20 | 1 | -17 | 5 | 2 |
| 30 Jun 20 | 1 | -18 | 5 | 2 |
| 31 Mar 20 | 2 | -17 | 5 | 1 |
| 31 Dec 19 | 2 | -16 | 5 | 1 |
| 30 Sep 19 | 2 | -17 | 5 | 0 |
| 30 Jun 19 | 2 | -16 | 5 | 0 |
| 31 Mar 19 | 2 | -25 | 5 | 0 |
| 31 Dec 18 | 2 | -23 | 4 | 0 |
| 30 Sep 18 | 2 | -21 | 4 | 0 |
| 30 Jun 18 | 2 | -20 | 4 | 0 |
| 31 Mar 18 | 2 | -7 | 5 | 0 |
| 31 Dec 17 | 2 | -11 | 5 | 0 |
| 30 Sep 17 | 2 | -5 | 5 | 0 |
| 30 Jun 17 | 2 | -4 | 4 | 0 |
| 31 Mar 17 | 2 | -3 | 4 | 0 |
| 31 Dec 16 | 2 | -3 | 4 | 0 |
| 30 Sep 16 | 2 | -10 | 4 | 0 |
| 30 Jun 16 | 2 | -10 | 4 | 0 |
| 31 Mar 16 | 2 | -10 | 4 | 0 |
| 31 Dec 15 | 2 | -7 | 4 | 0 |
| 30 Sep 15 | 2 | -5 | 3 | 0 |
| 30 Jun 15 | 2 | -5 | 3 | 0 |
| 31 Mar 15 | 1 | -5 | 3 | 0 |
| 31 Dec 14 | 1 | -6 | 3 | 0 |
| 30 Sep 14 | 1 | -7 | 3 | 0 |
| 30 Jun 14 | 1 | -6 | 3 | 0 |
| 31 Mar 14 | 2 | -7 | 3 | 0 |
| 31 Dec 13 | 2 | -5 | 3 | 0 |
Quality Earnings: PBIO is currently unprofitable.
Growing Profit Margin: PBIO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PBIO is unprofitable, and losses have increased over the past 5 years at a rate of 12.4% per year.
Accelerating Growth: Unable to compare PBIO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PBIO is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.7%).
Return on Equity
High ROE: PBIO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.